Topics
HSA Post-marketing Vigilance Guidance 2026
HSA Post-marketing Vigilance Guidance 2026
Record details
- Also known as
- ["HSA post-marketing vigilance","therapeutic product adverse-event reporting Singapore","CTGTP vigilance guidance"]
- Evidence profile
- mixed
Dates describe this record’s own period and applicability. A verification date does not mean a rule is currently in force.
Sources
Collection as of 2026-10-07 · An expanding collection. Published counts show available knowledge, not complete coverage of Singapore.